Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

20 results
Display

Ramelteon for Delayed Sleep-wake Phase Disorder: A Case Report

Takeshima M, Shimizu T, Ishikawa H, Kanbayashi T

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):167-169.
  • doi: 10.9758/cpn.2020.18.1.167
Recently developed melatonin receptor agonists are expected to be effective for delayed sleep-wake phase disorder (DSWPD). To date, however, no study has described the effect of melatonin receptor agonists on...
Low-dose Quetiapine-induced Syndrome of Inappropriate Antidiuretic Hormone in a Patient with Traumatic Brain Syndrome

Kang SG, Choi SH, Kim HY, Kim HY, Bae JN, Lee JS, Kim WH

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):164-166.
  • doi: 10.9758/cpn.2020.18.1.164
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by hyponatremia, low serum osmolality, and clinical euvolemia in the absence of diuretic medication. And the causes of SIADH are various,...
Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series

Kamei H, Yamada H, Hatano M, Hanya M, Yamada S, Iwata N

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):159-163.
  • doi: 10.9758/cpn.2020.18.1.159
In Japan, drug therapy for schizophrenia is characterized by high-dose antipsychotic polypharmacy, which is an uncommon approach internationally. In this study, we reduced the number of antipsychotic agents in 5...
Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study

Pae CU, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):153-158.
  • doi: 10.9758/cpn.2020.18.1.153
Objective: This study was done for collection of real world data of Aripiprazole Once Monthly (AOM) in patients with schizophrenia. Methods: The observation was up to 12 months from the first...
Dextromethorphan Protect the Valproic Acid Induced Downregulation of Neutrophils in Patients with Bipolar Disorder

Lu RB, Chang YH, Lee SY, Wang TY, Cheng SL, Chen PS, Yang YK, Hong JS, Chen SL

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):145-152.
  • doi: 10.9758/cpn.2020.18.1.145
Objective: Valproic acid (VPA) is an anticonvulsant and commonly long term used as a mood stabilizer for patients with mood disorders. However its chronic effects on the hematological changes were...
ALDH2 Gene: Its Effects on the Neuropsychological Functions in Patients with Opioid Use Disorder Undergoing Methadone Maintenance Treatment

Lee PW, Wang TY, Chang YH, Lee SY, Chen SL, Wang ZC, Chen PS, Chu CH, Huang SY, Tzeng NS, Lee IH, Chen KC, Yang YK, Hong JS, Lu RB

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):136-144.
  • doi: 10.9758/cpn.2020.18.1.136
Objective: Patients with opioid use disorder (OUD) have impaired attention, inhibition control, and memory function. The aldehyde dehydrogenase 2 (ALDH2 ) gene has been associated with OUD and ALDH2 gene...
Mismatch Negativity Indices as a Prognostic Factor for Remission in Schizophrenia

Kim JS, Kwon YJ, Lee HY, Lee HS, Kim S, Shim Sh

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):127-135.
  • doi: 10.9758/cpn.2020.18.1.127
Objective: Mismatch negativity (MMN) is known to be associated with neuro-cognition and functional outcomes. Remission and recovery rates are related to the neuro-cognition of patients with schizophrenia. The present study...
Gender-based Multilevel Analysis of Influential Factors for Suicide Attempts among At-risk Non-referred Adolescents in Korea

Lee Y, Lee D, Hong HJ

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):116-126.
  • doi: 10.9758/cpn.2020.18.1.116
Objective: Effective suicide prevention for at-risk adolescents requires increased access to medical treatment. Investigating the unique characteristics of suicide in this vulnerable at-risk non-referred sample can contribute to establishing effective...
Plasma Apelin, Visfatin and Resistin Levels in Patients with First Episode Psychosis and Chronic Schizophrenia

Sahpolat M, Ari M, Kokacya MH

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):109-115.
  • doi: 10.9758/cpn.2020.18.1.109
Objective: This study aims to investigate the possible relationship between plasma concentrations of apelin, visfatin and resistin levels of first episode psychosis patients and chronic schizophrenia patients. Methods: A total number...
Age-related Effects of Heroin on Gene Expression in the Hippocampus and Striatum of Cynomolgus Monkeys

Choi MR, Jin YB, Bang SH, Im CN, Lee Y, Kim HN, Chang KT, Lee SR, Kim DJ

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):93-108.
  • doi: 10.9758/cpn.2020.18.1.93
Objective: The aim of this study was to investigate differentially expressed genes and their functions in the hippocampus and striatum after heroin administration in cynomolgus macaques of different ages. Methods: Cynomolgus...
Protective Effects of Citicoline and Benfotiamine Each Alone and in Combination on Streptozotocin-induced Memory Impairment in Mice

Safavi M, Hosseini-Sharifabad A, Seyed-Yousefi Y, Rabbani M

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):81-92.
  • doi: 10.9758/cpn.2020.18.1.81
Objective: Diabetes mellitus is associated with cognitive disorders such as Alzheimer’s disease. Studies have shown that citicoline and benfotiamine can improve memory and learning through different mechanism of actions. The...
Effect of Omega-3 and Korean Red Ginseng on Children with Attention Deficit Hyperactivity Disorder: An Open-Label Pilot Study

Lee J, Lee A, Kim JH, Shin YM, Kim SJ, Cho WD, Lee SI

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):75-80.
  • doi: 10.9758/cpn.2020.18.1.75
Objective: The purpose of the present study was to evaluate the efficacy of omega-3 and Korean red ginseng on improving attention deficit hyperactivity disorder (ADHD) symptoms and cognitive function in...
Metformin Attenuates Liver Fat Content: Finding from Schizophrenia Patients with Olanzapine-induced Weight Gain

Wang L, Chen Y, Sui Yc, Tan Xq, Zhou Z, Li N, Xu Lp

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):67-74.
  • doi: 10.9758/cpn.2020.18.1.67
Objective: This study was performed to evaluate the efficacy of metformin on liver fat content (LFC) in first episode schizophrenia patients with olanzapine-induced weight gain, and the relationship between the...
Frontal Alpha Asymmetry Moderated by Suicidal Ideation in Patients with Major Depressive Disorder: A Comparison with Healthy Individuals

Roh SC, Kim JS, Kim S, Kim Y, Lee SH

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):58-66.
  • doi: 10.9758/cpn.2020.18.1.58
Objective: Frontal alpha asymmetry (FAA) of electroencephalography (EEG) has been studied to differentiate patients with major depressive disorder (MDD) from healthy controls (HC). However, inconsistent results have been obtained thus...
Acceptance of the Deltoid Muscle Injection of Aripiprazole Long-acting Injectable in the Patients with Schizophrenia

Kamei H, Homma Y, Takeuchi I, Hajitsu G, Tozawa K, Hatano M, Fukui A, Hanya M, Yamada S, Iwata N

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):49-57.
  • doi: 10.9758/cpn.2020.18.1.49
Objective: To improve poor medication adherence in schizophrenic patients, long-acting injectable (LAI) antipsychotics are used. However, it has not yet become common in Japan. Recently, aripiprazole LAI was approved for...
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders

Piacentino D, Kotzalidis GD, Schoretsanitis G, Paulzen M, Haen E, Cappelletti S, Giupponi G, Grözinger M, Conca A

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):41-48.
  • doi: 10.9758/cpn.2020.18.1.41
Objective: Therapeutic drug monitoring helps clinicians in choosing the right drug and adjust its dose in specific patients. To this end, we aimed to assess time patterns of risperidone and...
Elevated Neutrophil to Lymphocyte Ratio in Older Adults with Cocaine Use Disorder as a Marker of Chronic Inflammation

Soder HE, Berumen AM, Gomez KE, Green CE, Suchting R, Wardle MC, Vincent J, Teixeira AL, Schmitz JM, Lane SD

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):32-40.
  • doi: 10.9758/cpn.2020.18.1.32
Objective: The neutrophil to lymphocyte ratio (NLR) is a non-specific, easy-to-obtain marker of inflammation associated with morbidity and mortality in systemic, psychiatric, and age-related inflammatory conditions. Given the growing trend...
The Influence of Current Mood States on Screening Accuracy of the Mood Disorder Questionnaire

Wang HR, Bahk WM, Yoon BH, Kim MD, Jung YE, Min KJ, Hong J, Woo YS

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):25-31.
  • doi: 10.9758/cpn.2020.18.1.25
Objective: In this study we investigated whether current mood states of patients with bipolar disorder have an influence on the screening accuracy of the Mood Disorder Questionnaire (MDQ). Methods: A total...
Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing

Hong J, Bang M

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):10-24.
  • doi: 10.9758/cpn.2020.18.1.10
Schizophrenia is a debilitating psychiatric disorder with a substantial socioeconomic and humanistic burden. Currently available treatment strategies mostly rely on antipsychotic drugs, which block dopaminergic effects in the mesolimbic pathway...
Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future

Fabbri C, Serretti A

  • Clin Psychopharmacol Neurosci.
  • 2020 Feb;18(1):1-9.
  • doi: 10.9758/cpn.2020.18.1.1
Pharmacogenetic testing is a useful and increasingly widespread tool to assist in antidepressant prescription. More than ten antidepressants (including tricyclics, selective serotonin reuptake inhibitors and venlafaxine) have already genetic biomarkers...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr